Contact

Continued Momentum Drives Optimistic 2026 Plastics M&A Outlook

February 10, 2026

From transaction volume to EBITDA multiples, key indicators for plastics M&A are trending upward as 2026 begins, according to PMCF Investment Banking Managing Director John Hart.

In an interview with Plastics News on the 2026 M&A outlook, Hart noted that plastics M&A improved throughout 2025.

“There are always positives and negatives in the market, but we’re seeing gradual improvement as we come into 2026,” PMCF’s Hart said. “We’re seeing some nice momentum and transactions getting done.”

Based on PMCF’s Plastics M&A proprietary data and industry updates, Hart told Plastics News that there were an estimated 420 transactions in the industry in 2025, up about 5 percent compared to 2024.

The article, which reviews specialty plastics sectors including distribution, rubber/composites, injection molding, film and sheet, thermoforming and end markets, also discusses recent private equity interest in the industry. Hart also said EBITDA multiples for plastics deals have continued to improve since peaking in 2021, after declines in 2022 and 2023.

“We’ve been seeing gradual improvement in plastics M&A throughout 2025,” Hart said. “The tariff situation set us back in the first quarter, but that was short-lived and the market’s been improving.”

 

To read the Plastics News article, click here

To learn more about PMCF’s Plastics expertise, click here

More Articles

After a year defined by uneven activity and macro uncertainty, M&A momentum enters 2026 with improving financing conditions, renewed buyer confidence, and substantial capital on the sidelines, creating a more constructive environment for well-positioned middle-market distributors.

Read More

After years of volatility and transformation, the Human Capital Management (HCM) industry now finds itself navigating a landscape where geopolitical tensions and technological acceleration collide to create both unique challenges and new frontiers for growth.

Read More

Thirty years ago, PMCF Investment Banking set out with a clear mission: to redefine how middle‑market businesses approach M&A.

Read More

Medtech is entering 2026 with a healthier M&A environment supported by improved financing conditions, resilient sector performance, and a more straightforward path for strategic buyers and private equity.

Read More

The best exit strategies in food and beverage aren’t lucky, they’re meticulously planned years in advance.

Read More